Fuchs Kamila, Janek Tomasz, Karpl Mateusz, Władyczyn Anna, Ejfler Jolanta, John Łukasz
Faculty of Chemistry, University of Wrocław, 14 F. Joliot-Curie, 50-383 Wrocław, Poland.
Department of Biotechnology and Food Microbiology, Wrocław University of Environmental and Life Sciences, 37 Chełmońskiego, 51-630 Wrocław, Poland.
Inorg Chem. 2025 Apr 7;64(13):6460-6469. doi: 10.1021/acs.inorgchem.4c05156. Epub 2025 Mar 25.
This work introduces a novel class of hybrid antimicrobial agents by integrating sulfone and sulfonamide functionalities with polyhedral oligomeric silsesquioxanes (POSSs). By employing efficient synthetic protocols, we have successfully prepared both sulfone (ethylvinylsulfone-POSS and phenylethylsulfone-POSS) and sulfonamide (benzenesulfonamide-POSS, -toluenesulfonamide-POSS, 3-fluorobenzenesulfonamide-POSS, and 2-naphthalenesulfonamide-POSS) derivatives with high yields (73-90%). All derivatives were examined using Fourier transform infrared spectroscopy, multinuclear (H, C, F, and Si) NMR spectroscopy, MALDI-ToF MS spectrometry, and elemental analysis. Additionally, the crystal structure of the -toluenesulfonamide-POSS hybrid was revealed. The unique cage-like POSS structure not only imparts enhanced thermal and chemical stability, a common feature of silsesquioxane-based hybrids, but also boosts the lipophilic character of these compounds, thereby facilitating their interaction with microbial membranes. This interaction, likely resulting in membrane disruption and cell lysis, translates into potent antimicrobial activity (against , , , , and )─especially against Gram-positive bacteria─at remarkably low minimum inhibitory concentrations in the range from 125 to 3000 μM. In turn, and were more susceptible compared to Gram-negative bacteria and . The strategic incorporation of POSSs into these sulfur-based moieties represents a significant breakthrough, opening new avenues for the development of advanced antimicrobial coatings and therapeutic agents in the fight against antibiotic resistance.
这项工作通过将砜和磺酰胺官能团与多面体低聚倍半硅氧烷(POSS)相结合,引入了一类新型的混合抗菌剂。通过采用高效的合成方案,我们成功地高产率(73 - 90%)制备了砜(乙烯基乙基砜 - POSS和苯乙基砜 - POSS)和磺酰胺(苯磺酰胺 - POSS、对甲苯磺酰胺 - POSS、3 - 氟苯磺酰胺 - POSS和2 - 萘磺酰胺 - POSS)衍生物。所有衍生物均通过傅里叶变换红外光谱、多核(氢、碳、氟和硅)核磁共振光谱、基质辅助激光解吸电离飞行时间质谱和元素分析进行了检测。此外,还揭示了对甲苯磺酰胺 - POSS杂化物的晶体结构。独特的笼状POSS结构不仅赋予了基于倍半硅氧烷的杂化物增强的热稳定性和化学稳定性这一共同特征,还增强了这些化合物的亲脂性,从而促进它们与微生物膜的相互作用。这种相互作用可能导致膜破坏和细胞裂解,转化为强大的抗菌活性(针对金黄色葡萄球菌、表皮葡萄球菌、蜡样芽孢杆菌、大肠杆菌和白色念珠菌)——尤其是对革兰氏阳性菌——在125至3000 μM的极低最低抑菌浓度下。反过来,与革兰氏阴性菌大肠杆菌和白色念珠菌相比,金黄色葡萄球菌和表皮葡萄球菌更易受影响。将POSS策略性地引入这些含硫基团代表了一个重大突破,为开发对抗抗生素耐药性的先进抗菌涂层和治疗剂开辟了新途径。